+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Thyroid Cancer Diagnostics Market by Technology, Sample Type, Biomarker Type, Application, End User - Global Forecast to 2030- Product Image
Thyroid Cancer Diagnostics Market by Technology, Sample Type, Biomarker Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Thyroid Cancer Diagnostics Market by Technology, Sample Type, Biomarker Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533182
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The thyroid cancer diagnostics market is undergoing significant transformation, driven by technology innovation, regulatory evolution, and the increasing demand for precise and early detection. Senior leaders face rising complexity in procurement and operational decisions as disruptive trends reshape clinical pathways, supply chains, and regional growth strategies.

Market Snapshot: Thyroid Cancer Diagnostics Market Overview

The global thyroid cancer diagnostics market expanded from USD 257.58 million in 2024 to USD 273.14 million in 2025, with the sector projected to achieve a CAGR of 5.76%, ultimately reaching USD 360.55 million by 2030. This sustained growth reflects widespread adoption of advanced molecular tools, the emergence of innovative biomarker technologies, and the evolution of patient-centric diagnostic models. Healthcare organizations are moving beyond traditional modalities and emphasizing seamless workflows, data-driven insights, and enhanced cost-effectiveness to optimize patient care and resource allocation.

Scope & Segmentation

This research delivers granular market intelligence with a clear focus on actionable segmentation and technology usage patterns:

  • Technology: Immunoassay (Chemiluminescence Immunoassay, ELISA), Immunohistochemistry, Next Generation Sequencing (Targeted Sequencing, Whole Exome Sequencing, Whole Genome Sequencing), Real Time PCR (Digital PCR, qPCR)
  • Sample Type: Blood Sample, Fine Needle Aspiration, Tissue Biopsy
  • Biomarker Type: Epigenetic Markers (DNA Methylation, miRNA), Genetic Markers (BRAF, RAS, TERT), Protein Markers (Calcitonin, Thyroglobulin)
  • Application: Diagnosis, Prognosis, Recurrence Monitoring, Therapy Monitoring
  • End User: Academic Research Institutes (Cancer Research Centers, University Laboratories), Ambulatory Care Centers (Imaging Centers, Specialized Clinics), Diagnostic Laboratories (Chain Laboratories, Independent Laboratories), Hospitals (Private Hospitals, Public Hospitals)
  • Region: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, among others)
  • Key Companies: F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc., QIAGEN N.V., Siemens Healthineers AG, Illumina Inc., Hologic, Inc., Danaher Corporation, Sysmex Corporation, bioMérieux S.A.

Key Takeaways for Decision-Makers

  • Emerging molecular diagnostics, such as next-generation sequencing and liquid biopsy, are advancing precision in thyroid cancer detection and monitoring.
  • Artificial intelligence tools accelerate image interpretation and enhance consistency in immunohistochemistry results, supporting efficient clinical workflows.
  • Regional regulatory and reimbursement landscapes are shaping adoption rates, with value-based models incentivizing investments in clinically validated assays.
  • Growth opportunities are highly nuanced across technology, biomarker, and end-user segments, creating distinct avenues for targeted innovation and commercialization.
  • Collaborative research and academic-industry partnerships are accelerating assay validation and expanding access to emerging modalities, particularly in underserved areas.
  • Strategic alliances and product bundling among leading suppliers help laboratories streamline procurement while adapting to evolving market and regulatory demands.

Tariff Impact: Navigating Changing Supply Chain Dynamics

Recently implemented United States tariffs on imported diagnostic reagents and instruments have introduced new pressures on cost management and supply chain reliability. Laboratories and manufacturers are reevaluating sourcing strategies, prioritizing domestic production, bulk procurement, and closer ties with local distributors to mitigate risk. These measures—while fostering resilience—highlight the continued vulnerability of global supply networks in the face of shifting policy landscapes.

Methodology & Data Sources

This report draws on extensive primary research, including interviews with laboratory directors, industry leaders, and technical experts. Secondary analysis leverages peer-reviewed publications, regulatory filings, company disclosures, and industry databases. Triangulation and cross-validation methods were used throughout to ensure data accuracy and objectivity at every stage of the research process.

Why This Report Matters

  • Enables senior executives to make strategic decisions grounded in actionable segmentation and regional trends across the thyroid cancer diagnostics market.
  • Provides clarity on disruptive technologies, supply chain risks, and regulatory adaptation, supporting robust procurement and investment planning.
  • Delivers a comprehensive view of competitive positioning, unlocking opportunities to align innovation and partnership strategies for scalable growth.

Conclusion

Leading organizations that anticipate technological, regulatory, and regional shifts are best positioned to thrive in this evolving space. By leveraging actionable insights, senior stakeholders can drive effective transformation and capitalize on the market’s most dynamic opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Thyroid Cancer Diagnostics Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.2.1. Chemiluminescence Immunoassay
8.2.2. ELISA
8.3. Immunohistochemistry
8.4. Next Generation Sequencing
8.4.1. Targeted Sequencing
8.4.2. Whole Exome Sequencing
8.4.3. Whole Genome Sequencing
8.5. Real Time PCR
8.5.1. Digital PCR
8.5.2. qPCR
9. Thyroid Cancer Diagnostics Market, by Sample Type
9.1. Introduction
9.2. Blood Sample
9.3. Fine Needle Aspiration
9.4. Tissue Biopsy
10. Thyroid Cancer Diagnostics Market, by Biomarker Type
10.1. Introduction
10.2. Epigenetic Markers
10.2.1. DNA Methylation
10.2.2. miRNA
10.3. Genetic Markers
10.3.1. BRAF
10.3.2. RAS
10.3.3. TERT
10.4. Protein Markers
10.4.1. Calcitonin
10.4.2. Thyroglobulin
11. Thyroid Cancer Diagnostics Market, by Application
11.1. Introduction
11.2. Diagnosis
11.3. Prognosis
11.4. Recurrence Monitoring
11.5. Therapy Monitoring
12. Thyroid Cancer Diagnostics Market, by End User
12.1. Introduction
12.2. Academic Research Institutes
12.2.1. Cancer Research Centers
12.2.2. University Laboratories
12.3. Ambulatory Care Centers
12.3.1. Imaging Centers
12.3.2. Specialized Clinics
12.4. Diagnostic Laboratories
12.4.1. Chain Laboratories
12.4.2. Independent Laboratories
12.5. Hospitals
12.5.1. Private Hospitals
12.5.2. Public Hospitals
13. Americas Thyroid Cancer Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Thyroid Cancer Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Thyroid Cancer Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. QIAGEN N.V.
16.3.5. Siemens Healthineers AG
16.3.6. Illumina Inc.
16.3.7. Hologic, Inc.
16.3.8. Danaher Corporation
16.3.9. Sysmex Corporation
16.3.10. bioMérieux S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. THYROID CANCER DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. THYROID CANCER DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. THYROID CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. THYROID CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. THYROID CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. THYROID CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY MIRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BRAF, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TERT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CALCITONIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THYROGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHAIN LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 93. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 95. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 96. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 97. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 99. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 100. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 101. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 102. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 105. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 106. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 107. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 111. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 112. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 120. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 122. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 186. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 187. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 188. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 189. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 190. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 192. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 193. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 196. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 197. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 198. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 201. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 202. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 203. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 204. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 207. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 211. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 212. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 213. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 231. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 232. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 233. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 234. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 235. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 236. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 237. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 238. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 241. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 242. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 243. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 246. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 247. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 248. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 250. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 252. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 253. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 256. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 257. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 258. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 304. DENMARK THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. DENMARK THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 306. DENMARK THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 307. DENMARK THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2030 (USD MILLION)
TABLE 308. DENMARK THYR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Thyroid Cancer Diagnostics market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Illumina Inc.
  • Hologic, Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • bioMérieux S.A.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 273.14 Million
Forecasted Market Value ( USD ) by 2030 $ 360.55 Million
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report by Cancer Type (Papillary Carcinoma, Follicular Carcinoma), Technique (Imaging, Biopsy, Blood Test), End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report by Cancer Type (Papillary Carcinoma, Follicular Carcinoma), Technique (Imaging, Biopsy, Blood Test), End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Thyroid Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Thyroid Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Thyroid Cancer Diagnostics Market Report 2025 - Product Image

Thyroid Cancer Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Thyroid Cancer Drugs Market by Patient Age, Mode Of Administration, Distribution Channel, Therapy Type, End User - Global Forecast to 2030 - Product Image

Thyroid Cancer Drugs Market by Patient Age, Mode Of Administration, Distribution Channel, Therapy Type, End User - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.